Læknaneminn - 01.04.1996, Síða 88

Eftirvirkni sýklalyfja
system. Antimicrobial Agents and Chemotherapy
1991 ;2658 - 2661.
11. Guðmundsson S, Turnidge J, Vogelman B et al. The post
antibiotic effect in vivo. IrProceedings of 13th
International Congress of Chemotherapy ed. K H Spitzy
and K Karrer. Verlag H. Egerrmann, Vienna 1983; 117:68-
70
12. Renneberg J og Walder M. A mouse model for simulta-
neous pharmacokinetic and efficacy studies of antibiotics
at sites of infection. J. Antimicrob. Chemother.1988; 22:
51-60
13. Guðmundsson S, Vogelman B og Craig WA. The
postantibiotic effect - relevance to clinical practice, Insight
into the treatment of serious infections 1988;2:l:61-69
14. Guðmundsson S, Einarsson S, Erlendsdóttir H, Mofifat J et
al. The post-antibiotic effect of antimicrobial comb-
inations in a neutropenic murine thigh model. Journal of
Antimicrobial Chemotherapy 1993; 177 - 191.
15. Valdimarsdóttir M, Einarsson S, Erlendsdóttir H, et al.
Dosing Studies and Postantibiotic Effects of Antimicrobi-
al Combinations in an Animal model. In: Einhorn J, Nord
C E, Norrby S R ed. Recent advances in chemotherapy:
proceedings of the 18th International Congress of
Chemotherapy, Washington 1994; 475-477.
16. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice
daily gentamicin in patients with serious infections.
Lancet 1993; 341:335-339
17. Tange RA, Dreschler WA, Prins JM, et al. Ototoxity and
nephrotoxity of gentamicin vs. netilmycin in patients with
serious infections. Clinical otolaryngology 1995;20:118-
123
18. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience
with a once daily aminoglycoside program administerated
to 2184 adult patients. Antimicrobial Agents and
Chemotherapy 1995;39:650-655.
LÆKNANEMINN
78
1. tbl. 1996, 49. árg.